Table 5.
Univariate analyses of various clinicopathological parameters in relation to survival of patients with bladder tumor
| Variables | Patients | Progression-free survival(PFS) | Overall survival(OS) | ||
|---|---|---|---|---|---|
| (n = 120) | 5-year survival (%) (n = 103) | P-Value | 5-year survival (%) (n = 61) | P-Value | |
| Sex | 0.051 | 0.363 | |||
| Male | 87 | 78(75.7%) | 42(68.9%) | ||
| Female | 33 | 25(24.3%) | 19(31.1%) | ||
| Age (years) | 0.108 | 0.591 | |||
| ≤ 70 | 64 | 58(56%) | 34(55%) | ||
| > 70 | 56 | 45(44%) | 27(45%) | ||
| Stage | 0.175 | 0.016 | |||
| pTa-T1 | 76 | 6871.8% | 45(74%) | ||
| ≥PT2 | 44 | 3528.2% | 16(26%) | ||
| Grade | 0.008 | 0.018 | |||
| LG | 41 | 40(38.8%) | 27(38%) | ||
| HG | 79 | 63(61.2%) | 34(62%) | ||
| Slug | 0.457 | 0.479 | |||
| + | 75 | 63(61%) | 40(66%) | ||
| - | 45 | 40(39%) | 21(34%) | ||
| Twist | 0.018 | 0.069 | |||
| + | 53 | 41(40%) | 22(36%) | ||
| - | 67 | 62(60%) | 39(64%) | ||
| Snail | 0.732 | 0.502 | |||
| + | 19 | 16(15%) | 11(18%) | ||
| - | 101 | 87(85%) | 50(82%) | ||
| E-cadherin | 0.000 | 0.005 | |||
| + | 89 | 86(83.5%) | 52(85%) | ||
| - | 31 | 17(16.5%) | 9(15%) |